Comparative Seroepidemiologic Analysis of Chlamydophila Pneumoniae Infection using Microimmunofluorescence, Enzyme Immunoassay and Neutralization Test: Implications for Serodiagnosis. - Wikidata - awgldk - TriplyDB

Comparative Seroepidemiologic Analysis of Chlamydophila Pneumoniae Infection using Microimmunofluorescence, Enzyme Immunoassay and Neutralization Test: Implications for Serodiagnosis.

Comparative Seroepidemiologic Analysis of Chlamydophila Pneumoniae Infection using Microimmunofluorescence, Enzyme Immunoassay and Neutralization Test: Implications for Serodiagnosis.

http://www.wikidata.org/entity/Q35533027

about

Anti-chlamydial IgG Neutralizing Ability in Nonzoonotic Atypical Community Acquired Respiratory Tract Infections.Preparation and evaluation of monoclonal antibodies against chlamydial protease-like activity factor to detect Chlamydia pneumoniae antigen in early pediatric pneumonia.

P2860

Q35685740-AF654017-8DE9-4D8C-B6D9-98D400E8C79E Q37841506-23E6838F-26B6-40F0-A017-D55A55EAA5B8

P2860

Comparative Seroepidemiologic Analysis of Chlamydophila Pneumoniae Infection using Microimmunofluorescence, Enzyme Immunoassay and Neutralization Test: Implications for Serodiagnosis.

http://www.wikidata.org/entity/Q35533027

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Comparative Seroepidemiologic ...... mplications for Serodiagnosis.

@ast

Comparative Seroepidemiologic ...... mplications for Serodiagnosis.

@en

type

label

Comparative Seroepidemiologic ...... mplications for Serodiagnosis.

@ast

Comparative Seroepidemiologic ...... mplications for Serodiagnosis.

@en

prefLabel

Comparative Seroepidemiologic ...... mplications for Serodiagnosis.

@ast

Comparative Seroepidemiologic ...... mplications for Serodiagnosis.

@en

P1433

Q35533027-A511263E-45CF-4BD8-B33B-55392BD195E0

P1476

Q35533027-7EE981FD-1CF3-4B30-8C23-3DB0A27312BF

P2093

Q35533027-7264B434-ECC5-4A2B-8BCD-BE15C62FEDD5

Q35533027-9C341895-CF9E-4041-BFB5-824D99CE1453

Q35533027-D5083C19-A6C2-4744-9028-287958E3CB68

P2860

Q35533027-1246E5DB-4DD5-492E-9BB7-B13D1B31AB6F

Q35533027-1BCA82E1-1799-4E61-AE5D-91A9CFCF66A9

Q35533027-1CCFF373-5015-4580-975E-E84113900EDC

Q35533027-1D3300F8-3519-457E-8B81-ED57C59613CA

Q35533027-289954A0-D99B-47B9-B8E5-D056919B91DA

Q35533027-3DD8D62C-AAC6-4D49-92E7-195D32B47D98

Q35533027-5FAA91B2-B8CE-4944-9CAE-C31E1AC53870

Q35533027-620BA17F-5C5D-4153-A265-855EC962BA3A

Q35533027-63FF2376-44A1-48F3-944E-2C753F8926F1

Q35533027-658DE5B5-6F98-4D6D-87C0-F55E9B519D77

P2888

Q35533027-DFBDACA8-5588-442C-BCB4-78DA95715C2A

P304

Q35533027-4A2C7490-7437-4E02-AC54-662A9B89BCC2

P31

Q35533027-BFE347B2-92C2-4E19-B682-3620C00324DF

P356

Q35533027-55BB079A-8552-4E92-9803-77E81947C326

P433

Q35533027-A9E77F7C-CFAF-402D-BE91-2DF4BA0568B6

P478

Q35533027-6C2FCD43-C956-46A7-B456-99C41CEB5BDB

P50

Q35533027-04482E21-6EEC-4376-B5CA-A8367C22A062

P577

Q35533027-78B08F35-57EC-452B-81AD-049F347D7FC0

P5875

Q35533027-6AA5D1B5-9D93-4AA1-89F2-42FE8CBBF3DD

P698

Q35533027-A78858A3-3CB9-4161-8A59-66AB57C89296

P932

Q35533027-49693E7D-E3DA-4848-85DB-3C80292ECA1E

P356

S12088-011-0168-4

P1433

Indian Journal of Microbiology

P1476

Comparative Seroepidemiologic ...... mplications for Serodiagnosis.

@en

P2093

Gabriel W J Yee

http://www.w3.org/2001/XMLSchema#string

M C Phoon

http://www.w3.org/2001/XMLSchema#string

Vincent T K Chow

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae.

Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies

Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae

The use of serologic tests for the diagnosis of chlamydial infections.

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections.

Reactions of polyclonal and neutralizing anti-p54 monoclonal antibodies with an isolated, species-specific 54-kilodalton protein of Chlamydia pneumoniae.

Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods.

Role of Chlamydia pneumoniae in atherosclerosis.

Chlamydophila pneumoniae.

P2888

s12088-011-0168-4

P304

223-229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12088-011-0168-4

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225086494

http://www.w3.org/2001/XMLSchema#string

P698

22654169

http://www.w3.org/2001/XMLSchema#string

P932

3209895

http://www.w3.org/2001/XMLSchema#string